. Author manuscript; available in PMC: 2010 Oct 1.

Published in final edited form as: J Pain. 2009 Jul 22;10(10):1001–1011. doi: 10.1016/j.jpain.2009.06.002

Table 1.

New Additions of Pain Medications

Tricyclic antidepressants

Selective norepinephrine or serotonin reuptake inhibitors

Cyclooxygenase-2 inhibitors

Topical analgesics (e.g., Lidocaine patch; Non- steroid anti-inflammatory drug patch)

Alpha-2 receptor agonist (Tizanadine)

Transdermal opioid (Fentanyl patch)

Fentanyl HCL patient-controlled transdermal system

Transdermal buprenorphine

Intrathecal drugs (e.g., Ziconotide)

Triptans (5-HT receptor agonists)

Opioid receptor agonist/SNRI/SSRI combination (e.g., Tramadol)

Sublingual opioid

α₂-δ Ca²⁺ subunit blocker (Gabapentin/pregabalin)

Anticonvulsants

Others (e.g., Topiramate)